Suchergebnisse - "Campbell, Christina"

PubPharm (141)

51

Are pre-pregnancy weight fluctuations and adherence to prenatal nutrition and exercise recommendations related to excessive gestational weight gain?

enthalten in: Journal of behavioral medicine | 2020

von Nagpal, T. | Prapavessis, H. | Campbell, C. | +3

52

Unusual case of preoperative hypoxaemia

enthalten in: Thorax | 2020

von Ridge, P. | Cullivan, S. | Campbell, C. | +2

53

Sequential Introduction of Exercise First Followed by Nutrition Improves Program Adherence During Pregnancy : a Randomized Controlled Trial

enthalten in: International journal of behavioral medicine | 2020

von Nagpal, T. | Prapavessis, H. | Campbell, C. | +6

54

Sequential Introduction of Exercise First Followed by Nutrition Improves Program Adherence During Pregnancy: a Randomized Controlled Trial

enthalten in: International journal of behavioral medicine | 2019

von Nagpal, T. | Prapavessis, H. | Campbell, C. | +6

55

Sequential Introduction of Exercise First Followed by Nutrition Improves Program Adherence During Pregnancy: a Randomized Controlled Trial

enthalten in: International journal of behavioral medicine | 2019

von Nagpal, T. | Prapavessis, H. | Campbell, C. | +6

56

Sequential Introduction of Exercise First Followed by Nutrition Improves Program Adherence During Pregnancy: a Randomized Controlled Trial

enthalten in: International journal of behavioral medicine | 2019

von Nagpal, T. | Prapavessis, H. | Campbell, C. | +6

57

A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis : a protocol for the CLEAR clinical trial

enthalten in: Trials | 2019

von Bradley, J. | Anand, R. | O'Neill, B. | +29

58

A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: a protocol for the CLEAR clinical trial

enthalten in: Trials | 2019

von Bradley, J. | Anand, R. | O’Neill, B. | +18

59

A 2 × 2 factorial, randomised, open-label trial to determine the clinical and cost-effectiveness of hypertonic saline (HTS 6%) and carbocisteine for airway clearance versus usual care over 52 weeks in adults with bronchiectasis: a protocol for the CLEAR clinical trial

enthalten in: Trials | 2019

von Bradley, J. | Anand, R. | O’Neill, B. | +18

60

Discovery of Axelopran (TD-1211) : A Peripherally Restricted μ-Opioid Receptor Antagonist

enthalten in: ACS medicinal chemistry letters | 2019

von Long, D. | Armstrong, S. | Beattie, D. | +13